Doctor profile · Federal record
Dr. James Fischkoff, MD
Rheumatology Physician (CMS: Rheumatology) · Freehold, NJ
- NPI 1972895373
- Accepts Medicare
- MIPS 94.1 / 100 · 2023
- 18 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
4247 Route 9 N, Building 1
Freehold, NJ 077288307
(732) 780-7650
Credentials & registration
- NPI registered
- May 2011 — 15 yrs on file
- Profile last updated
- November 19, 2014
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- New Jersey #25MA09290800
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1972895373. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
86,503
Distinct HCPCS
10
Medicare allowed
$1,381,362
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 33,800 | 15 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 16,126 | 23 | $13 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 16,000 | 14 | $5 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,375 | 21 | $40 | |
J0897 |
Injection, denosumab, 1 mg | 6,300 | 86 | $23 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 2,525 | 17 | $33 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,271 | 608 | $138 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 287 | 92 | $145 | |
J1030 |
Injection, methylprednisolone acetate, 40 mg | 198 | 111 | $8 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 195 | 129 | $82 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 4,184. This provider delivers 21× the peer median.Open Payments
Industry payments received
All-time total
$315
Transactions
10
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 5 | $173.93 | |
| Zimmer Biomet Holdings, Inc. | 1 | $71.45 | |
| GlaxoSmithKline, LLC. | 2 | $28.54 | |
| BIOTRONIK NRO, Inc. | 1 | $21.49 | |
| UCB, Inc. | 1 | $19.61 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,385
Patients
827
Total drug cost
$452,776
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 426 | 151 | $19,108 |
| Prednisone | Generic | 365 | 115 | $4,701 |
| Hydroxychloroquine Sulfate | Generic | 331 | 120 | $29,886 |
| Celecoxib | Generic | 202 | 75 | $8,686 |
| Tramadol Hcl | Generic | 165 | 28 | $2,144 |
| Leflunomide | Generic | 142 | 54 | $13,569 |
| Allopurinol | Generic | 105 | 31 | $2,017 |
| Duloxetine Hcl | Generic | 105 | 39 | $5,844 |
| Gabapentin | Generic | 97 | 35 | $3,490 |
| Folic Acid | Generic | 94 | 36 | $481 |
Hospital affiliations
Frequently asked questions
What is Dr. James Fischkoff's medical specialty?
Dr. James Fischkoff practices Rheumatology Physician in Freehold, NJ.
Where does Dr. James Fischkoff practice?
Dr. James Fischkoff practices at 4247 Route 9 N, Freehold, NJ 077288307. Office phone: 7327807650.
What is Dr. James Fischkoff's NPI?
Dr. James Fischkoff's National Provider Identifier (NPI) is 1972895373, issued by NPPES.
Does Dr. James Fischkoff accept Medicare assignment?
Yes. Dr. James Fischkoff accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. James Fischkoff commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717). Source: CMS Medicare Physician & Other Practitioners file.